Company news

Ningxia Zhongke Biotechnology Co., Ltd. Class A (SSE:600165) news

Ningxia Zhongke Biotechnology Co., Ltd. Class A news releases on 6ix. Latest, Aug 29, 2026: "NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Semi-annual Report for 2026

View Ningxia Zhongke Biotechnology Co., Ltd. Class A →

Press releases & updates

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Semi-annual Report for 2026

August 28, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on the Removal of Other Risk Warnings and Temporary Suspension of Trading

August 24, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on Progress of Litigation Involving a Dispute over the Right of Recourse

August 20, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on Application to Withdraw Other Risk Warnings on Shares

August 14, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on Shareholding Increase Plan by Certain Directors and All Senior Management

July 24, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on Investment and Construction of Relevant Projects

July 23, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on Litigation Involved by the Company and Its Subsidiary

July 14, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on Expected Loss in Semi-annual Performance for 2026

July 13, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Indicative Announcement on Abnormal Fluctuations and Risks in Stock Trading

July 3, 2026

"NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."Announcement on SSE's Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

June 30, 2026

Announcement on Progress in External Investment and Completion of Industrial and Commercial Change Registration and Obtaining of the Business License

June 29, 2026

Announcement on Changing Implementation Entity for Outward Investment Projects

June 12, 2026

Announcement on Progress in Providing Guarantee for Holding Subsidiary

June 5, 2026

Announcement on Progress in Litigation Involving a Recourse Dispute

May 22, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 14, 2026

Announcement on Attending Collective Reception Day for Investors of Listed Companies in Ningxia Jurisdiction and 2025 Annual Performance Meeting

May 8, 2026

Report for Q1 2026

April 29, 2026

Announcement on the Filing of Infringement Lawsuits by the Company and Its Subsidiaries

April 27, 2026

Announcement on Providing Guarantee for Holding Subsidiary

April 23, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

April 13, 2026

Announcement on Resolutions of the 3rd Meeting of the 10th Board of Directors

March 27, 2026

Announcement on New and Accumulative Litigation

March 17, 2026

Announcement on Completion of Industrial and Commercial Change Registration for Registered Capital and Renewal of Business License

March 9, 2026

Announcement on Litigation Involved by the Company and Its Subsidiary

March 6, 2026

Announcement on Results of the Judicial Auction of Shares of the Company Held by Shanghai Zhongneng Enterprise Development (Group) Co., Ltd.

February 4, 2026

Announcement on Outward Investment in Establishing Subsidiaries

January 30, 2026

Announcement on Expected Loss in Performance for 2025

January 19, 2026

Announcement on the Removal of Delisting Risk Warning and Continuation of Other Risk Warnings, along with Temporary Suspension of Trading

January 12, 2026

Announcement on Unfreezing of Partial Bank Accounts of Subsidiaries

January 7, 2026

Announcement on Completion of the Reorganization Plan for the Company and Its Subsidiaries

December 31, 2025

Announcement on Freezing of Partial Bank Accounts of Subsidiaries

December 30, 2025

Announcement on Resolutions of the 1st Meeting of the 10th Board of Directors

December 29, 2025

Announcement on Risk Warning in Stock Trading

December 19, 2025

Indicative Announcement on Abnormal Fluctuations and Risks in Stock Trading

December 18, 2025

Announcement on Completion of Share Transfer to the Restructuring Investors

December 15, 2025

Announcement on Planning to Increase Registered Capital and Amend the Articles of Association

December 11, 2025

Announcement on Receiving the Full Restructuring Investment from the Restructuring Investor

December 10, 2025

Indicative Announcement on the Ex-Rights Matters of Capital Reserve Conversion into Share Capital under the Restructuring Plan

December 9, 2025

Announcement on the Implementation of Capital Reserve Conversion into Share Capital under the Restructuring Plan

December 4, 2025

Further Indicative Announcement on the Risk of Potential Significant Downward Adjustment of the Company’s Stock Price Due to Ex-Rights

December 3, 2025

Indicative Announcement on the Risk of Potential Significant Downward Adjustment of the Company’s Stock Price Due to Ex-Rights

November 26, 2025

Indicative Announcement on Change in Equity of Shareholders and Proposed Change of Controlling Shareholder and Actual Controller

November 19, 2025

*ST宁科关于控股股东股份被第二次司法拍卖的进展公告

November 18, 2025

Announcement on Approval of the Restructuring Plan for the Company and Its Subsidiaries by Court Ruling

November 13, 2025

Announcement on Convening and Voting Results of the Creditors' Meeting Related to the Reorganization of the Company and Its Subsidiaries

November 7, 2025

Report for Q3 2025

October 30, 2025

Announcement on Convening the 3rd Creditors' Meeting for the Restructuring of Holding Subsidiary NINGXIA ZHONGKE BIOLOGICAL NEW MATERIALS CO., LTD.

October 22, 2025

Announcement on Court Permission for Wholly-owned Subsidiary Ningxia Xiri Hengli International Trade Co., Ltd. to Continue Business Operations During Reorganization

October 21, 2025

Announcement on Extension of Debt Declaration for the Reorganization of the Subsidiary

October 16, 2025

Indicative Announcement on 2nd Judicial Auction of the Controlling Shareholder's Shares

October 13, 2025

Older →